Daiichi's Novel EZH Candidate Progresses In New Consortium Trial

Euro Partners Brought On Board

B-Cell lymphoma
Daiichi Asset Moves Ahead For B-Cell Malignancies • Source: Shutterstock

More from Clinical Trials

More from R&D